See also this year's filing and all EDGAR filings for this company.
PDF Report 0001496323_2022_IGM_Biosciences_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001496323')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001496323, IGM Biosciences Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 240,747,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 28,495,000 |
| 3 | remainder_Assets | 28,885,000 |
| 4 | LiabilitiesCurrent | 27,780,000 |
| 5 | LiabilitiesNoncurrent | 25,439,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 38,297,000 |
| 9 | ResearchAndDevelopmentExpense | 127,026,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -165,164,000 |
| 13 | remainder_ComprehensiveNetIncome | -92,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 298,127,000 |
| 1 | Liabilities | 53,219,000 |
| 2 | Expenses | 165,323,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 244,908,000 |
| 5 | NetIncome | -330,487,000 |
| 6 | ComprehensiveNetIncome | -330,533,000 |
| 7 | BaseVar | 340,962,500 |
| 8 | EconomicCapitalRatio | 0.516 |
Edgar->Model Mapping
Feature Distribution
Change over Time
